This is the third blog in this series on novel trials, following an initial update on clinical trials and a second on a survey that was launched in December 2019.
The survey is now closed, and thank you to everyone who completed it for us. The results are important to us and have provided valuable insight into what we currently do and how we can strive to improve in the future.
As previously mentioned, we will now be running a workshop, in the form of a webinar held over 2 afternoons.
The aim of this workshop is for MHRA to present examples of how sponsors and researchers can improve the regulatory aspects of novel trials, providing some initial solutions that can be taken forward. The workshop will also share the results from the survey on novel trials.
The survey also asked stakeholders their opinions on the advice services available from MHRA and responses and further information will be included in Day 2 discussions.
Anyone can register and join the workshop, from across varying backgrounds, including commercial and non-commercial. It is also hoped that learning points will be disseminated to colleagues following the workshop to help those not able to attend. After the workshop the presentations and any discussion aspects will also be published in a workshop report.
Registration is now open.
So do sign up – we look forward to seeing you in October!
To hear about future MHRA events (including the proposed workshop) and to receive updates on our products and services, please also subscribe to our mailing list.